32 min listen
Eligibility for Anti-Amyloid Treatment
ratings:
Length:
23 minutes
Released:
Oct 12, 2023
Format:
Podcast episode
Description
Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment. Read the related article in Neurology. Visit NPUb.org/Podcast for associated article links.
Released:
Oct 12, 2023
Format:
Podcast episode
Titles in the series (100)
November 13 2007 Issue: A midlife stroke surge among women in the United States by Neurology® Podcast